JPRN-jRCTs032210201已完成未知
A study of maintenance of skeletal and respitatory muscle quantity by magnetic stimulation for COVID-19
Sakai Tomoko0 个研究点目标入组 0 人开始时间: 2021年7月16日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
The study will be terminated without being initiated due to difficulties in obtaining cases.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Healthy persons who do not have cardiopulmonary diseases
- •2) Men or women more than 19years old at informed consent
- •3) Persons from whom informed consent were obtained with sufficient understanding and by their free will after detailed explanation on participating this study
- •1) Patients with severe COVID-19 in ICU of Tokyo Medical and Dental University
- •2) men or women who are more than 19 years at informed consent
- •3) Patients from whose proxies informed consent were obtained with sufficient understanding and by their free will after detailed explanation on participating this study ( from patients if possible)
排除标准
- •1) pace-maker user
- •2) The patient who is judged to be inappropriate as a study subject by a study responsibility doctor and a study allotment doctor (the following study responsibility doctors)
研究者
相似试验
已完成
不适用
Correlation analysis between pouchitis disease activity and measuring fecal concentration of calprotectipouchitisJPRN-UMIN000014915Hyogo College of Medicine15
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190098Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190099Takimoto Rishu40
已完成
2 期
Phase II study of continuation maintenance by use of nab-Paclitaxel and Bevacizumab after induction chemotherapy of Carboplatin and nab-Paclitaxel pulse bevacizumab in chemotherapy-naïve patients with Stage IIIB / IV non-squamous and non-small cell lung cancer.on-small and non-squamous cell lung cancerJPRN-UMIN000012450Department of Respiratory Medicine National Center for Global health and Medicine-Hospital42